Literature DB >> 12493598

Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats.

Robert Vink1, Christine A O'Connor, Alan J Nimmo, Deanne L Heath.   

Abstract

Although a number of studies have demonstrated that magnesium improves acute motor and cognitive outcome after traumatic brain injury, others have failed to show positive effects on cognitive outcome and none have examined persistent functional deficits. The present study shows that severe impact-acceleration induced, diffuse traumatic brain injury in rats produced profound motor and cognitive deficits that persisted for at least 4 weeks after trauma. Intravenous administration of magnesium sulfate (250 micromoles/kg) at 30 min after injury significantly improved rotarod (sensorimotor) and open field (stress/anxiety) performance, and led to a faster rate of recovery in the Barnes maze (learning). We conclude that posttraumatic magnesium administration attenuates long-term motor and cognitive deficits after traumatic brain injury, and that this improvement may include some reduction of post-traumatic stress and anxiety.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12493598     DOI: 10.1016/s0304-3940(02)01244-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

Review 2.  Magnesium neuroprotection is limited in humans with acute brain injury.

Authors:  J Andrew McKee; Randall P Brewer; Gary E Macy; Cecil O Borel; James D Reynolds; David S Warner
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  When basic research doesn't translate to the bedside--lessons from the magnesium brain trauma study.

Authors:  John W Miller; Raimondo D'Ambrosio
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

4.  Acute neuroimmune modulation attenuates the development of anxiety-like freezing behavior in an animal model of traumatic brain injury.

Authors:  Krista M Rodgers; Florencia M Bercum; Danielle L McCallum; Jerry W Rudy; Lauren C Frey; Kirk W Johnson; Linda R Watkins; Daniel S Barth
Journal:  J Neurotrauma       Date:  2012-04-26       Impact factor: 5.269

Review 5.  Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Authors:  Niklas Marklund; Lars Hillered
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.

Authors:  J Marc Simard; Michael Kilbourne; Orest Tsymbalyuk; Cigdem Tosun; John Caridi; Svetlana Ivanova; Kaspar Keledjian; Grant Bochicchio; Volodymyr Gerzanich
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 7.  [Nutritional therapy in traumatic brain injury : Update 2012].

Authors:  H E Marcus; F A Spöhr; B W Böttiger; S Grau; S A Padosch
Journal:  Anaesthesist       Date:  2012-08       Impact factor: 1.041

8.  A novel PARP inhibitor L-2286 in a rat model of impact acceleration head injury: an immunohistochemical and behavioral study.

Authors:  Erzsébet Kövesdi; Péter Bukovics; Valérie Besson; József Nyirádi; János Lückl; József Pál; Balázs Sümegi; Tamás Dóczi; István Hernádi; András Büki
Journal:  Int J Mol Sci       Date:  2010-03-26       Impact factor: 5.923

9.  Chronic dietary magnesium-L-threonate speeds extinction and reduces spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Nita Hoxha; Joseph L Luchsinger; Morgan M Rogers; Nathanael R Wiles
Journal:  Pharmacol Biochem Behav       Date:  2013-03-06       Impact factor: 3.533

10.  Novel model of frontal impact closed head injury in the rat.

Authors:  Michael Kilbourne; Reed Kuehn; Cigdem Tosun; John Caridi; Kaspar Keledjian; Grant Bochicchio; Thomas Scalea; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.